BX Swiss TOP 30 CHF
1.375,77
PKT
-0,96
PKT
-0,07
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.12.17 | UBS buy | UBS AG | |
| 11.12.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.12.17 | Nestlé buy | Goldman Sachs Group Inc. | |
| 11.12.17 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.12.17 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 11.12.17 | UBS buy | HSBC | |
| 08.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.17 | Roche Equal-Weight | Morgan Stanley | |
| 08.12.17 | UBS kaufen | Deutsche Bank AG | |
| 08.12.17 | Roche Neutral | UBS AG | |
| 08.12.17 | Roche overweight | JP Morgan Chase & Co. | |
| 07.12.17 | Roche Neutral | UBS AG | |
| 07.12.17 | Swiss Re Reduce | Commerzbank AG | |
| 07.12.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.12.17 | Nestlé buy | Goldman Sachs Group Inc. | |
| 07.12.17 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 06.12.17 | Roche Neutral | UBS AG | |
| 06.12.17 | Roche buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Nestlé buy | Kepler Cheuvreux | |
| 06.12.17 | Novartis Underperform | Merrill Lynch & Co., Inc. | |
| 05.12.17 | Givaudan overweight | JP Morgan Chase & Co. | |
| 05.12.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 05.12.17 | UBS buy | Goldman Sachs Group Inc. | |
| 05.12.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 04.12.17 | Givaudan Hold | Deutsche Bank AG | |
| 04.12.17 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 01.12.17 | Roche Equal-Weight | Morgan Stanley | |
| 01.12.17 | Novartis overweight | Morgan Stanley | |
| 01.12.17 | UBS kaufen | Independent Research GmbH | |
| 01.12.17 | UBS buy | Citigroup Corp. | |
| 01.12.17 | Roche Outperform | Bernstein Research | |
| 01.12.17 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 01.12.17 | UBS Outperform | RBC Capital Markets | |
| 01.12.17 | UBS buy | Goldman Sachs Group Inc. | |
| 01.12.17 | UBS overweight | JP Morgan Chase & Co. | |
| 01.12.17 | UBS buy | UBS AG | |
| 30.11.17 | UBS overweight | JP Morgan Chase & Co. | |
| 30.11.17 | UBS buy | UBS AG | |
| 30.11.17 | UBS buy | Deutsche Bank AG | |
| 30.11.17 | Swiss Re Sell | UBS AG |